{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-040184","form_type":"8-K","ticker":"HIND","cik":"0001427570","company_name":"Vyome Holdings, Inc","filed_at":"2025-04-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.264107+00:00","generated_at":"2026-05-23T04:51:53.572272+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ReShape Lifesciences amends asset purchase deal; price cut to $2.25M, deadline to June 30","bullets":["Exercise price under Asset Purchase Agreement reduced from $5.16M to $2.25M.","Termination date extended from March 31, 2025 to June 30, 2025.","Amendment dated April 25, 2025, between ReShape and Ninjour Health International Limited.","Original Asset Purchase Agreement was entered into on July 8, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-040184","json":"https://secwatch.observer/filing/0001104659-25-040184.json","markdown":"https://secwatch.observer/filing/0001104659-25-040184.md","text":"https://secwatch.observer/filing/0001104659-25-040184.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/0001104659-25-040184-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427570/000110465925040184/tm2513212d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T04:51:53.572272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}